Related Experiment Video

Updated: Jul 22, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Lipid disorders: justification of methods and goals of treatment

J B Braunstein1, A Cheng, G Cohn

  • 1Ciccarone Center for the Prevention of Heart Disease, Division of Cardiology, Department of Internal Medicine, The Johns Hopkins Hospital, Baltimore, MD 21287, USA.

Chest
|September 14, 2001
PubMed

Insights

Dyslipidemia increases coronary heart disease (CHD) risk. This review examines challenges and strategies for optimizing lipid management in high-risk patients despite guideline adherence issues.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Preventive Medicine

Background:

  • Dyslipidemia is a significant risk factor for coronary heart disease (CHD).
  • Statins effectively reduce CHD events by lowering low-density lipoprotein cholesterol (LDL-C).
  • Despite evidence, many patients with hyperlipidemia undertreated.

Purpose of the Study:

  • To review challenges in achieving lipid management goals.
  • To discuss strategies for optimizing lipid-lowering treatment in CHD-risk patients.

Main Methods:

  • Literature review of primary and secondary prevention studies.
  • Analysis of factors contributing to suboptimal lipid management.
  • Examination of current treatment guidelines and adherence.

Main Results:

  • Low-density lipoprotein cholesterol (LDL-C) reduction with statins is proven effective for CHD prevention.
  • Physician adherence, patient compliance, and comorbidities impede treatment success.
  • Optimizing lipid management requires addressing these multifaceted challenges.

Conclusions:

  • Effective lipid management is crucial for reducing cardiovascular events.
  • Overcoming barriers to guideline adherence and patient compliance is essential.
  • Tailored strategies are needed to optimize lipid therapy in high-risk populations.

More Related Videos

Lipidomics and Transcriptomics in Neurological Diseases09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

Assessing Whole-Body Lipid-Handling Capacity in Mice07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...